John F. Gilmer
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases 12
- Inflammatory mediators and NSAID effects 7
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 7
- Peptidase Inhibition and Analysis 5
- Organic Chemistry top 10%
-
- Protease and Inhibitor Mechanisms 9
- Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases 12
- Inflammatory mediators and NSAID effects 7
-
- Computational Drug Discovery Methods 10
-
- Antiplatelet Therapy and Cardiovascular Diseases 7
-
- Helicobacter pylori-related gastroenterology studies 6
- Co-authors
- Carlos MedinaShane O’SullivanJohn M. ClancyAna Luı́sa Simplı́cioMarek W. RadomskiJohn WalshAideen LongRuchika Sharma
- Journals
- The Journal of Physiology (1 paper)Biochemical Journal (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- IrelandCanadaUnited States
In The Last Decade
John F. Gilmer
68 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 115
- Pharmacology 267
- Oncology 337
- Organic Chemistry 317
- Cancer Research 147
- Pharmacology 70
Countries citing papers authored by John F. Gilmer
This map shows the geographic impact of John F. Gilmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. Gilmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. Gilmer more than expected).
Fields of papers citing papers by John F. Gilmer
This network shows the impact of papers produced by John F. Gilmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. Gilmer. The network helps show where John F. Gilmer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John F. Gilmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 11 | |
| 3 | 2020 | 3 | |
| 4 | 2017 | 10 | |
| 5 | 2013 | 93 | |
| 6 | 2013 | 10 | |
| 7 | 2012 | 16 | |
| 8 | 2012 | 19 | |
| 9 | 2012 | 2 | |
| 10 | 2012 | 10 | |
| 11 | 2011 | 53 | |
| 12 | 2011 | 45 | |
| 13 | 2011 | 16 | |
| 14 | 2010 | 26 | |
| 15 | 2010 | 16 | |
| 16 | 2008 | 4 | |
| 17 | 2005 | 9 | |
| 18 | 2003 | 14 | |
| 19 | 2002 | 32 | |
| 20 | 2001 | 20 |
About John F. Gilmer
John F. Gilmer is a scholar working on Pharmacology, Filtration and Separation and Cancer Research, having authored 68 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (12 papers), Computational Drug Discovery Methods (10 papers), Protease and Inhibitor Mechanisms (9 papers), Drug Transport and Resistance Mechanisms (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Inflammatory mediators and NSAID effects (7 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Pharmacology (267 citations), Oncology (337 citations) and Organic Chemistry (317 citations). John F. Gilmer has collaborated with scholars based in Ireland, Canada and United States. Frequent co-authors include Carlos Medina, Shane O’Sullivan, John M. Clancy, Ana Luı́sa Simplı́cio, Marek W. Radomski, John Walsh, Aideen Long, Ruchika Sharma, Justin J. Perry and Anthony P. Davis. Their work appears in journals such as The Journal of Physiology, Biochemical Journal and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.